DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $389,000 | +49.6% | 19,298 | +176.7% | 0.03% | +40.9% |
| Q2 2021 | $260,000 | -45.4% | 6,975 | -73.7% | 0.02% | -29.0% |
| Q3 2020 | $476,000 | -48.7% | 26,474 | -27.4% | 0.03% | -51.6% |
| Q2 2020 | $927,000 | +159.7% | 36,477 | +88.0% | 0.06% | +146.2% |
| Q1 2020 | $357,000 | -0.3% | 19,407 | +19.5% | 0.03% | +23.8% |
| Q4 2019 | $358,000 | +222.5% | 16,239 | +56.7% | 0.02% | +200.0% |
| Q4 2018 | $111,000 | – | 10,366 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |